190 related articles for article (PubMed ID: 36848323)
1. Cell therapies for spinal cord injury: a review of the clinical trials and cell-type therapeutic potential.
Ribeiro BF; da Cruz BC; de Sousa BM; Correia PD; David N; Rocha C; Almeida RD; Ribeiro da Cunha M; Marques Baptista AA; Vieira SI
Brain; 2023 Jul; 146(7):2672-2693. PubMed ID: 36848323
[TBL] [Abstract][Full Text] [Related]
2. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
[TBL] [Abstract][Full Text] [Related]
3. Time is spine: a review of translational advances in spinal cord injury.
Badhiwala JH; Ahuja CS; Fehlings MG
J Neurosurg Spine; 2018 Dec; 30(1):1-18. PubMed ID: 30611186
[TBL] [Abstract][Full Text] [Related]
4. Natural history of neurological improvement following complete (AIS A) thoracic spinal cord injury across three registries to guide acute clinical trial design and interpretation.
Aimetti AA; Kirshblum S; Curt A; Mobley J; Grossman RG; Guest JD
Spinal Cord; 2019 Sep; 57(9):753-762. PubMed ID: 31182786
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.
Fawcett JW; Curt A; Steeves JD; Coleman WP; Tuszynski MH; Lammertse D; Bartlett PF; Blight AR; Dietz V; Ditunno J; Dobkin BH; Havton LA; Ellaway PH; Fehlings MG; Privat A; Grossman R; Guest JD; Kleitman N; Nakamura M; Gaviria M; Short D
Spinal Cord; 2007 Mar; 45(3):190-205. PubMed ID: 17179973
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Efficacy and Safety of Cell Transplantation for Spinal Cord Injury: A Systematic Review and Bayesian Network Meta-Analysis.
Xu X; Liang Z; Lin Y; Rao J; Lin F; Yang Z; Wang R; Chen C
Front Cell Neurosci; 2022; 16():860131. PubMed ID: 35444516
[TBL] [Abstract][Full Text] [Related]
7. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III.
Bracken MB; Holford TR
J Neurosurg; 2002 Apr; 96(3 Suppl):259-66. PubMed ID: 11990832
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of activated olfactory ensheathing cells by curcumin strengthens regeneration and recovery of function after spinal cord injury in rats.
Guo J; Cao G; Yang G; Zhang Y; Wang Y; Song W; Xu Y; Ma T; Liu R; Zhang Q; Hao D; Yang H
Cytotherapy; 2020 Jun; 22(6):301-312. PubMed ID: 32279988
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.
Huang H; Xi H; Chen L; Zhang F; Liu Y
Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: study protocol for a randomized controlled trial.
Demirel A; Li J; Morrow C; Barnes S; Jansen J; Gower B; Kirksey K; Redden D; Yarar-Fisher C
Trials; 2020 May; 21(1):372. PubMed ID: 32366293
[TBL] [Abstract][Full Text] [Related]
12. Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs).
Gómez RM; Sánchez MY; Portela-Lomba M; Ghotme K; Barreto GE; Sierra J; Moreno-Flores MT
Glia; 2018 Jul; 66(7):1267-1301. PubMed ID: 29330870
[TBL] [Abstract][Full Text] [Related]
13. Recovery and regeneration after spinal cord injury: a review and summary of recent literature.
Lim PA; Tow AM
Ann Acad Med Singap; 2007 Jan; 36(1):49-57. PubMed ID: 17285186
[TBL] [Abstract][Full Text] [Related]
14. Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model.
Zhang L; Zhuang X; Chen Y; Xia H
Cell Transplant; 2019 Dec; 28(12):1585-1602. PubMed ID: 31665910
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients.
El-Kheir WA; Gabr H; Awad MR; Ghannam O; Barakat Y; Farghali HA; El Maadawi ZM; Ewes I; Sabaawy HE
Cell Transplant; 2014 Apr; 23(6):729-45. PubMed ID: 23452836
[TBL] [Abstract][Full Text] [Related]
16. Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury.
Kumar R; Htwe O; Baharudin A; Ariffin MH; Abdul Rhani S; Ibrahim K; Rustam A; Gan R
JMIR Res Protoc; 2016 Dec; 5(4):e230. PubMed ID: 27919862
[TBL] [Abstract][Full Text] [Related]
17. Natural History, Predictors of Outcome, and Effects of Treatment in Thoracic Spinal Cord Injury: A Multi-Center Cohort Study from the North American Clinical Trials Network.
Wilson JR; Jaja BNR; Kwon BK; Guest JD; Harrop JS; Aarabi B; Shaffrey CI; Badhiwala JH; Toups EG; Grossman RG; Fehlings MG
J Neurotrauma; 2018 Nov; 35(21):2554-2560. PubMed ID: 29665733
[TBL] [Abstract][Full Text] [Related]
18. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.
Xiao Z; Tang F; Zhao Y; Han G; Yin N; Li X; Chen B; Han S; Jiang X; Yun C; Zhao C; Cheng S; Zhang S; Dai J
Cell Transplant; 2018 Jun; 27(6):907-915. PubMed ID: 29871514
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and outcome of bone marrow derived stem cells transplanted via intramedullary route in acute complete spinal cord injury - A randomized placebo controlled trial.
Saini R; Pahwa B; Agrawal D; Singh PK; Gujjar H; Mishra S; Jagdevan A; Misra MC
J Clin Neurosci; 2022 Jun; 100():7-14. PubMed ID: 35367733
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial.
Zamani H; Soufizomorrod M; Oraee-Yazdani S; Naviafar D; Akhlaghpasand M; Seddighi A; Soleimani M
Spinal Cord; 2022 Jan; 60(1):63-70. PubMed ID: 34504283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
